Literature DB >> 1678399

Human immunodeficiency virus DNA is present in a high percentage of CD4+ lymphocytes of seropositive individuals.

K Hsia1, S A Spector.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infects predominantly CD4+ cells in human peripheral blood and infection is associated with CD4+ lymphocyte dysfunction in patients with AIDS. To determine the frequency of HIV-1 infection in CD4+ lymphocytes in vivo, peripheral blood CD4+ lymphocytes were isolated by fluorescence-activated cell sorting from HIV-1-infected persons with clinical disease ranging from asymptomatic to AIDS. Using standard and booster polymerase chain reaction analyses, study patients with AIDS and AIDS-related complex (ARC) were found to harbor the HIV-1 genome in at least 10% of CD4+ lymphocytes, and approximately 10-fold less infected cells were found in those with asymptomatic infection. In addition, the peripheral blood mononuclear cells from patients with ARC frequently contained a higher absolute number of HIV-1-infected CD4+ lymphocytes than those with AIDS or asymptomatic infection. It is likely that this high level of infection of CD4+ lymphocytes is the primary cause for the progressive immunologic deficiency observed in patients infected with HIV-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678399     DOI: 10.1093/infdis/164.3.470

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients.

Authors:  J R Clarke; A J Gates; R J Coker; J A Douglass; J D Williamson; D M Mitchell
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

2.  Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.

Authors:  J A LaBonte; T Patel; W Hofmann; J Sodroski
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Feline immunodeficiency virus infection: plasma, but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine.

Authors:  J Meers; G M del Fierro; R B Cope; H S Park; W K Greene; W F Robinson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Maintaining confidentiality in a look-back investigation of patients treated by a HIV-infected dentist.

Authors:  P M Arnow; T Chou; R Shapiro; E J Sussman
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

5.  HIV type-1 infection of the cotton rat (Sigmodon fulviventer and S. hispidus).

Authors:  R J Langley; G A Prince; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification.

Authors:  S A Spector; R Merrill; D Wolf; W M Dankner
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 8.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

9.  Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution.

Authors:  J Embretson; M Zupancic; J Beneke; M Till; S Wolinsky; J L Ribas; A Burke; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy.

Authors:  Keith Shults; Leanne Flye-Blakemore; Bruce K Patterson; Tarek Elbeik
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.